US buys Lilly COVID antibody, as effectiveness questions remainThe US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million Share XUS buys Lilly COVID antibody, as effectiveness questions remainhttps://pharmaphorum.com/news/us-buys-300000-doses-lilly-covid-antibody/
Purdue to pay $8.3bn after admitting criminal charges in opioid caseAfter years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in Share XPurdue to pay $8.3bn after admitting criminal charges in opioid casehttps://pharmaphorum.com/news/purdue-to-pay-8-3bn-after-admitting-criminal-charges-in-opioid-case/
Teva charged in US price-fixing investigationThe US Department of Justice has charged Teva with conspiring with other pharma companies to fix prices for Share XTeva charged in US price-fixing investigationhttps://pharmaphorum.com/news/teva-charged-in-us-price-fixing-investigation/
Anger at US deal for Moderna’s ‘taxpayer-funded’ COVID-19 vaccineThe US government has signed another big coronavirus vaccine supply deal, snapping up 100 million doses of Moderna’s Share XAnger at US deal for Moderna’s ‘taxpayer-funded’ COVID-19 vaccinehttps://pharmaphorum.com/news-market-access/anger-at-us-deal-for-modernas-taxpayer-funded-covid-19-vaccine/
After final $600M opioid settlement, Indivior looks to the futureUK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in Share XAfter final $600M opioid settlement, Indivior looks to the futurehttps://pharmaphorum.com/news/after-final-600m-opioid-settlement-indivior-looks-to-the-future/
US places $1.95 billion order for Pfizer/BioNTech’s COVID-19 vaccineThe US government has agreed to pay Pfizer and BioNTech $1.95 billion to secure access to 100 million Share XUS places $1.95 billion order for Pfizer/BioNTech’s COVID-19 vaccinehttps://pharmaphorum.com/news/us-places-1-95-billion-order-for-pfizer-biontechs-covid-19-vaccine/
US snaps up first supplies of Regeneron’s COVID-19 antibodyHard on the heels of Regeneron moving its COVID-19 antibody cocktail into late-stage testing, the US government has Share XUS snaps up first supplies of Regeneron’s COVID-19 antibodyhttps://pharmaphorum.com/news/us-snaps-up-first-supplies-of-regenerons-covid-19-antibody/
Novartis pays $678 million to settle US kickback allegationsAnother nail has been hammered into the coffin of the pharma model of providing lavish entertainment and other Share XNovartis pays $678 million to settle US kickback allegationshttps://pharmaphorum.com/news/novartis-pays-678-million-to-settle-us-kickback-allegations/
Indivior ex-CEO could face jail time after opioid convictionThe resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea – Share XIndivior ex-CEO could face jail time after opioid convictionhttps://pharmaphorum.com/news/indivior-ex-ceo-could-face-jail-time-after-opioid-conviction/
